共 50 条
- [45] ORAL VALGANCICLOVIR AS EARLY PRE-EMPTIVE TREATMENT FOR CMV REACTIVATION AFTER ALLOGENEIC STEM CELL TRANSPLANTATION: A SINGLE CENTER EXPERIENCE IN 45 PATIENTS HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 184 - 184
- [50] Impact of letermovir prophylaxis in CMV reactivation and disease after allogenic hematopoietic cell transplantation: a real-world, observational study Annals of Hematology, 2024, 103 : 609 - 621